Return to study ST001779 main page

MB Sample ID: SA165043

Local Sample ID:2h TGF-β_4
Subject ID:SU001856
Subject Type:Cultured cells
Subject Species:Homo sapiens
Taxonomy ID:9606
Cell Biosource Or Supplier:ATCC
Cell Strain Details:Human Lung epithelial A549 cancer cells
Cell Passage Number:10
Cell Counts:5 million cells

Select appropriate tab below to view additional metadata details:


Subject:

Subject ID:SU001856
Subject Type:Cultured cells
Subject Species:Homo sapiens
Taxonomy ID:9606
Cell Biosource Or Supplier:ATCC
Cell Strain Details:Human Lung epithelial A549 cancer cells
Cell Passage Number:10
Cell Counts:5 million cells

Factors:

Local Sample IDMB Sample IDFactor Level IDLevel ValueFactor Name
2h TGF-β_4SA165043FL0197562h TGF-βTreatment

Collection:

Collection ID:CO001849
Collection Summary:A549 lung cancer cells were treated with control, ATP, TGF-beta and then collected according to sample preparation protocol.
Collection Protocol Filename:Collection protocol
Sample Type:Lung
Collection Method:Ice cold methanol (80%) using cell scrappers
Collection Location:150mm dish
Collection Frequency:Once
Collection Duration:1-2 sec
Volumeoramount Collected:1 ml
Storage Conditions:-80℃
Collection Vials:Polypropylene 1.5 ml tubes
Storage Vials:Polypropylene 1.5 ml
Collection Tube Temp:4C
Tissue Cell Quantity Taken:5 million

Treatment:

Treatment ID:TR001869
Treatment Summary:5 million A549 cells were treated with control (no treatment), 0.5 mM ATP or 10 ng/ml TGF-beta for 2, 6 and 12 hours.
Treatment:In vitro treatment with small molecules
Treatment Compound:0.5 mM ATP and 10 ng/ml TGF-beta
Treatment Dosevolume:10 ml DMEM media containing appropriate compounds
Cell Storage:37C; 5% CO2 incubator
Cell Growth Container:150 mm Dish tissue culture treated
Cell Media:DMEM (10% FBS; 1% Pen/Strep)
Cell Harvesting:after 2, 6 and 12 hours
Cell Pct Confluence:80%
Cell Media Lastchanged:NA

Sample Preparation:

Sampleprep ID:SP001862
Sampleprep Summary:5 × 106 A549 cells were treated with control (no treatment), 0.5 mM ATP or 10 ng/ml TGF-beta for 2, 6 and 12 hours. After treatment, cells were washed twice with deionized water and polar metabolites were then extracted with cryogenically cold 80% methanol/water mixture. LC-MS grade water, methanol, and acetonitrile (Fischer Scientific, PA, USA) were used. Methanol-extracted samples were then sonicated in cycles of sonication phase and rest phase for 10 minutes (5 second sonication phase and 10 seconds halt). The samples were then centrifuged at 13,000 rpm for 10 minutes and supernatant was then collected. Supernatants collected from in vitro and in vivo extraction were then lyophilized. Briefly, the supernatant was then lyophilized by using a speed vacuum evaporator. The samples were then dissolved into a mixture of acetonitrile/water (1:1; v/v).
Sampleprep Protocol Filename:Sample preparation protocol
Processing Method:CEll scrapping Quenching
Processing Storage Conditions:-80℃
Extraction Method:Quenching with Ice cold methanol
Extract Enrichment:Speed vaccum evaporator
Extract Storage:-80℃
Sample Resuspension:Acetonitrile/water (1:1)

Combined analysis:

Analysis ID AN002888 AN002889
Analysis type MS MS
Chromatography type Reversed phase Reversed phase
Chromatography system Agilent 1290 Agilent 1290
Column Poroshell 120 SB-C18 (100 x 2.1mm,2.7um) Poroshell 120 SB-C18 (100 x 2.1mm,2.7um)
MS Type ESI ESI
MS instrument type QTOF QTOF
MS instrument name Agilent 6545 QTOF Agilent 6545 QTOF
Ion Mode POSITIVE NEGATIVE
Units normalized normalized

Chromatography:

Chromatography ID:CH002141
Chromatography Summary:The entire LC/MS-MS experiment was performed in the Campus Chemical Instrumentation Center’s Mass Spectrometry and Proteomics facility at The Ohio State University. Lyophilized samples were dissolved in equal amounts of LC-MS grade water and acetonitrile and run with LC/MS-MS analysis, using an untargeted metabolomics approach by utilizing Agilent Q-TOF 6545 mass spectrometer connected to an Agilent 1290 UHPLC system with a Poroshell 120 SB-C18 (2 x 100 mm, 2.7 µm particle size) column. The LC gradient consisted of solvent A, H2O with 0.1 % Formic acid, and solvent B, 100 % acetonitrile at a 200 µL/min flow rate with an initial 2 % solvent B with a linear ramp to 95 % B at 15 min, holding at 95% B for 1 minutes, and back to 2 % B from 16 min and equilibration of 2 % B until min 32. A 5 µL volume sample was injected for each run and the top 5 ions were selected for data-dependent analysis with a 15 second exclusion window.
Instrument Name:Agilent 1290
Column Name:Poroshell 120 SB-C18 (100 x 2.1mm,2.7um)
Column Temperature:40
Flow Gradient:an initial 2 % solvent B with a linear ramp to 95 % B at 15 min, holding at 95% B for 1 minutes, and back to 2 % B from 16 min and equilibration of 2 % B until min 32.
Flow Rate:200 µL/min
Solvent A:100% water; 0.1% formic acid
Solvent B:100% acetonitrile
Chromatography Type:Reversed phase

MS:

MS ID:MS002681
Analysis ID:AN002888
Instrument Name:Agilent 6545 QTOF
Instrument Type:QTOF
MS Type:ESI
MS Comments:Masshunter software was used to collect the raw data. Progenesis was used for peak intergration.
Ion Mode:POSITIVE
  
MS ID:MS002682
Analysis ID:AN002889
Instrument Name:Agilent 6545 QTOF
Instrument Type:QTOF
MS Type:ESI
MS Comments:Masshunter software was used to collect the raw data. Progenesis was used for peak intergration.
Ion Mode:NEGATIVE
  logo